Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Consolaro

Showing results (111-120 of 178) with videos related to

Pageof 18
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic ArthritisErkan Demirkaya, Stefano Lanni, Francesca Bovis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 10, 2025
Toward a treat-to-target strategy in juvenile dermatomyositis: what are the suitable targets and optimal timing of their achievement?Jayne M MacMahon, Angelo Ravelli, Ana Isabel Rebollo-Giménez, et al.
Pediatric Rheumatology Online Journal|February 26, 2025
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinibValentina Natoli, Serena Palmeri, Ana Isabel Rebollo-Giménez, et al.
Frontiers in Immunology|May 19, 2023
Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkersFederica Raggi, Martina Bartolucci, Davide Cangelosi, et al.
Frontiers in Immunology|October 24, 2025
Novel Immune biomarkers for the early stratification of oligoarthritis patients at risk of developing polyarticular extensionFederica Raggi, Simone Pelassa, Francesca Antonini, et al.
Clinical and Experimental Rheumatology|September 26, 2025
Data from a multicentric international study unveils a neglected association between chronic non-bacterial osteomyelitis and inflammatory bowel diseasesCaterina Matucci-Cerinic, Yagmur Bayindir, Chiara Longo, et al.
Pediatric Rheumatology Online Journal|January 24, 2025
Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritisAna Isabel Rebollo-Giménez, Angela Pistorio, Silvia Maria Orsi, et al.
Rheumatology International|April 12, 2018
The Brazilian Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Taciana A Pedrosa Fernandes, Claudia Saad Magalhães, Sheila Knupp Oliveira, et al.
Arthritis Care & Research|May 28, 2011
Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritisAlessandro Consolaro, Nicolino Ruperto, Angela Pistorio, et al.
Pediatric Rheumatology Online Journal|September 7, 2022
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the "comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS" (STARS) trialMarco Burrone, Marta Mazzoni, Roberta Naddei, et al.
Pageof 18

Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic ArthritisErkan Demirkaya, Stefano Lanni, Francesca Bovis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 10, 2025
Toward a treat-to-target strategy in juvenile dermatomyositis: what are the suitable targets and optimal timing of their achievement?Jayne M MacMahon, Angelo Ravelli, Ana Isabel Rebollo-Giménez, et al.
Pediatric Rheumatology Online Journal|February 26, 2025
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinibValentina Natoli, Serena Palmeri, Ana Isabel Rebollo-Giménez, et al.
Frontiers in Immunology|May 19, 2023
Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkersFederica Raggi, Martina Bartolucci, Davide Cangelosi, et al.
Frontiers in Immunology|October 24, 2025
Novel Immune biomarkers for the early stratification of oligoarthritis patients at risk of developing polyarticular extensionFederica Raggi, Simone Pelassa, Francesca Antonini, et al.
Clinical and Experimental Rheumatology|September 26, 2025
Data from a multicentric international study unveils a neglected association between chronic non-bacterial osteomyelitis and inflammatory bowel diseasesCaterina Matucci-Cerinic, Yagmur Bayindir, Chiara Longo, et al.
Pediatric Rheumatology Online Journal|January 24, 2025
Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritisAna Isabel Rebollo-Giménez, Angela Pistorio, Silvia Maria Orsi, et al.
Rheumatology International|April 12, 2018
The Brazilian Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Taciana A Pedrosa Fernandes, Claudia Saad Magalhães, Sheila Knupp Oliveira, et al.
Arthritis Care & Research|May 28, 2011
Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritisAlessandro Consolaro, Nicolino Ruperto, Angela Pistorio, et al.
Pediatric Rheumatology Online Journal|September 7, 2022
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the "comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS" (STARS) trialMarco Burrone, Marta Mazzoni, Roberta Naddei, et al.
Pageof 18